Aslan Pharmaceuticals Limited Asset Turnover Ratio (ASLN), as of fourth quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Aslan Pharmaceuticals Limited  (NASDAQ: ASLN)
 

Aslan Pharmaceuticals Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Aslan Pharmaceuticals Limited asset turnover ratio, the ability of Aslan Pharmaceuticals Limited's assets to generate revenue in the fourth quarter 2023, increased sequentially to 0.37 in the fourth quarter (Dec 31 2023), ASLN's balance sheet remain strong.

Within sector 82 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2023 compared to the preceding quarter from 0 to 2295.

Asset Turnover Ratio Definition



ASLN Asset Turnover Ratio (Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Asset Change -59.75 % -59.75 % -14.48 % -59.75 % -35.27 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.37 - - - -
ASLN's Total Ranking # 2295 # 0 # 0 # 0 # 0
Seq. Asset Change 0.01 % -56.28 % 128.75 % -59.75 % 0.01 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 83
Healthcare Sector # 294
Overall Market # 2295

Asset Turnover Ratio Statistics
High Average Low
0.49 0.31 0.13
(Dec 31 2023)   (Dec 31 2019)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
Zynex inc   1.34 $ 184.322  Millions$ 137.990  Millions
Option Care Health Inc   1.33 $ 4,302.223  Millions$ 3,227.988  Millions
Myomo Inc   1.31 $ 19.182  Millions$ 14.667  Millions
Innovage Holding Corp   1.30 $ 720.796  Millions$ 554.155  Millions
Henry Schein Inc   1.30 $ 12,339.000  Millions$ 9,525.250  Millions
Cidara Therapeutics Inc   1.28 $ 90.012  Millions$ 70.055  Millions
Electromedical Technologies Inc   1.28 $ 1.349  Millions$ 1.051  Millions
Medpace Holdings Inc   1.27 $ 1,885.842  Millions$ 1,486.553  Millions
Viemed Healthcare Inc   1.27 $ 183.008  Millions$ 144.512  Millions
Biolase Inc   1.25 $ 48.724  Millions$ 38.856  Millions
Biofrontera Inc   1.24 $ 43.816  Millions$ 35.227  Millions
Biotricity Inc   1.24 $ 11.091  Millions$ 8.961  Millions
Infusystem Holdings Inc  1.23 $ 125.785  Millions$ 102.499  Millions
Idexx Laboratories Inc  1.22 $ 3,659.970  Millions$ 3,006.383  Millions
Nephros Inc   1.22 $ 13.405  Millions$ 11.023  Millions
Aesthetic Medical International Holdings Group Limited  1.21 $ 100.824  Millions$ 83.259  Millions
Pressure Biosciences Inc   1.21 $ 1.978  Millions$ 1.635  Millions
Hca Healthcare Inc   1.20 $ 64,968.000  Millions$ 54,276.250  Millions
Evolus Inc   1.18 $ 202.085  Millions$ 171.547  Millions
Warby Parker Inc   1.18 $ 669.224  Millions$ 568.695  Millions
Cadre Holdings inc   1.17 $ 481.726  Millions$ 410.145  Millions
Nrc Health  1.16 $ 148.580  Millions$ 127.627  Millions
Electromed Inc   1.16 $ 51.693  Millions$ 44.630  Millions
Xtant Medical Holdings Inc   1.16 $ 90.467  Millions$ 78.287  Millions
Molecular Templates Inc   1.15 $ 55.500  Millions$ 48.365  Millions
Irhythm Holdings Inc   1.14 $ 491.806  Millions$ 431.026  Millions
Evofem Biosciences Inc   1.14 $ 18.218  Millions$ 15.996  Millions
Puma Biotechnology Inc   1.13 $ 235.637  Millions$ 207.721  Millions
Mettler toledo International Inc   1.13 $ 3,788.309  Millions$ 3,356.147  Millions
Aveanna Healthcare Holdings Inc   1.12 $ 1,895.209  Millions$ 1,684.996  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.